By
Sam Wightwick2025-11-04T09:16:07
A newly developed peptide, WRPRFa, is giving scientists a clearer view of how the acid-sensing ion channel (ASIC3) drives pain signalling.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-03-07T10:55:58
Sponsored by Agilent
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud